dipyridamole has been researched along with Renal Insufficiency, Chronic in 1 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Renal Insufficiency, Chronic: Conditions in which the KIDNEYS perform below the normal level for more than three months. Chronic kidney insufficiency is classified by five stages according to the decline in GLOMERULAR FILTRATION RATE and the degree of kidney damage (as measured by the level of PROTEINURIA). The most severe form is the end-stage renal disease (CHRONIC KIDNEY FAILURE). (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dipyridamole treatment was associated with decreased odds for rapid eGFR decline [odds ratio, 0." | 1.40 | Dipyridamole treatment is associated with improved renal outcome and patient survival in advanced chronic kidney disease. ( Chen, HC; Hung, CC; Hwang, SJ; Kuo, HT; Lim, LM; Lin, HY; Lin, MY; Tsai, JC; Yang, ML, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hung, CC | 1 |
| Yang, ML | 1 |
| Lin, MY | 1 |
| Lin, HY | 1 |
| Lim, LM | 1 |
| Kuo, HT | 1 |
| Hwang, SJ | 1 |
| Tsai, JC | 1 |
| Chen, HC | 1 |
1 other study available for dipyridamole and Renal Insufficiency, Chronic
| Article | Year |
|---|---|
Dipyridamole treatment is associated with improved renal outcome and patient survival in advanced chronic kidney disease.
Topics: Creatinine; Demography; Dipyridamole; Female; Glomerular Filtration Rate; Humans; Kidney Failure, Ch | 2014 |